JP2017521436A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521436A5
JP2017521436A5 JP2017501154A JP2017501154A JP2017521436A5 JP 2017521436 A5 JP2017521436 A5 JP 2017521436A5 JP 2017501154 A JP2017501154 A JP 2017501154A JP 2017501154 A JP2017501154 A JP 2017501154A JP 2017521436 A5 JP2017521436 A5 JP 2017521436A5
Authority
JP
Japan
Prior art keywords
group
heteroatoms
alkyl group
membered ring
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017501154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017521436A (ja
JP6487527B2 (ja
Filing date
Publication date
Priority claimed from CN201410317076.7A external-priority patent/CN105330698B/zh
Application filed filed Critical
Priority claimed from PCT/CN2015/082605 external-priority patent/WO2016000581A1/zh
Publication of JP2017521436A publication Critical patent/JP2017521436A/ja
Publication of JP2017521436A5 publication Critical patent/JP2017521436A5/ja
Application granted granted Critical
Publication of JP6487527B2 publication Critical patent/JP6487527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017501154A 2014-07-04 2015-06-29 スピロ環アリールリン酸化物及びアリールリン硫化物(spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide) Active JP6487527B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201410317076.7A CN105330698B (zh) 2014-07-04 2014-07-04 螺环芳基磷氧化物和硫化物
CN201410317076.7 2014-07-04
CN201510350019 2015-06-23
CN201510350019.3 2015-06-23
PCT/CN2015/082605 WO2016000581A1 (zh) 2014-07-04 2015-06-29 螺环芳基磷氧化物和芳基磷硫化物

Publications (3)

Publication Number Publication Date
JP2017521436A JP2017521436A (ja) 2017-08-03
JP2017521436A5 true JP2017521436A5 (OSRAM) 2019-02-14
JP6487527B2 JP6487527B2 (ja) 2019-03-20

Family

ID=55018447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017501154A Active JP6487527B2 (ja) 2014-07-04 2015-06-29 スピロ環アリールリン酸化物及びアリールリン硫化物(spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide)

Country Status (7)

Country Link
US (1) US10053477B2 (OSRAM)
EP (1) EP3165530B1 (OSRAM)
JP (1) JP6487527B2 (OSRAM)
ES (1) ES2714576T3 (OSRAM)
PL (1) PL3165530T3 (OSRAM)
TW (1) TWI571471B (OSRAM)
WO (1) WO2016000581A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10053477B2 (en) 2014-07-04 2018-08-21 Qilu Pharmaceutical Co., Ltd. Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
JP6717457B2 (ja) 2017-01-23 2020-07-01 シージャーズォアン サガシティ ニュー ドラッグ デベロップメント カンパニー リミテッド Wee1阻害剤としての1,2−ジヒドロ−3H−ピラゾロ[3,4−d]ピリミジン−3−オン誘導体
WO2019027860A1 (en) * 2017-08-01 2019-02-07 Boehringer Ingelheim International Gmbh INTERMEDIATE COMPOUNDS AND METHODS
JP7085242B2 (ja) * 2017-12-21 2022-06-16 深▲チェン▼市塔吉瑞生物医薬有限公司 キナーゼ活性を阻害するためのアリールホスフィンオキシド
WO2019120121A1 (zh) * 2017-12-21 2019-06-27 深圳市塔吉瑞生物医药有限公司 用于抑制激酶活性的二苯氨基嘧啶类化合物
US11046720B2 (en) * 2018-04-20 2021-06-29 Guizhou Inochini Technology Co., Ltd Dimethylphosphine oxide compound
WO2020147702A1 (en) * 2019-01-17 2020-07-23 Betta Pharmaceuticals Co., Ltd Egfr inhibitors, compositions and methods thereof
IL293965A (en) 2019-12-19 2022-08-01 Janssen Pharmaceutica Nv History of Spiro straight chain transformed
EP4306115A4 (en) * 2021-07-05 2024-11-20 Qilu Pharmaceutical Co., Ltd. Pharmaceutical composition, and preparation method therefor and application thereof
WO2023078411A1 (zh) * 2021-11-05 2023-05-11 南京明德新药研发有限公司 氮杂螺环化合物
CN118338913A (zh) * 2022-01-18 2024-07-12 齐鲁制药有限公司 螺环芳基磷氧化物与抗vegf抗体的药物组合
TW202339767A (zh) * 2022-01-18 2023-10-16 大陸商齊魯製藥有限公司 螺環芳基磷氧化物與抗egfr抗體的聯用藥物組合物及其用途
CN118891264A (zh) * 2022-08-01 2024-11-01 齐鲁制药有限公司 螺环胺类芳基磷氧化合物的晶型及其制备方法
WO2025202955A1 (en) 2024-03-28 2025-10-02 Pi Industries Ltd. Fused bicyclic compounds and their use as pest control agents

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0305929D0 (en) 2003-03-14 2003-04-23 Novartis Ag Organic compounds
TWI389893B (zh) * 2007-07-06 2013-03-21 Astellas Pharma Inc 二(芳胺基)芳基化合物
US9273077B2 (en) * 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
PL2300013T5 (pl) 2008-05-21 2025-04-28 Takeda Pharmaceutical Company Limited Pochodne fosforu jako inhibitor kinazy
JP2013509412A (ja) * 2009-11-02 2013-03-14 アボット・ラボラトリーズ 多標的キナーゼ阻害における新規な足場としてのイミダゾピリジン類
US20130288240A1 (en) * 2010-05-21 2013-10-31 Cell Signaling Technology, Inc. Alk and ros kinase in cancer
BR112013008816A2 (pt) 2010-10-14 2016-06-28 Ariad Pharma Inc método de tratamento de câncer direcionado ao egfr resistente à erlotinibe ou gefitinibe, ou uso de um sal farmacêuticamente aceito em um indivíduo
FR2974088A1 (fr) 2011-04-12 2012-10-19 Pf Medicament Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
CN102731413A (zh) 2011-04-15 2012-10-17 上海医药工业研究院 一种脲类化合物、其制备方法、其中间体及其应用
WO2013138210A1 (en) 2012-03-14 2013-09-19 Ning Xi Substituted cyclic compounds and methods of use
WO2013148857A1 (en) 2012-03-28 2013-10-03 Synta Pharmaceuticals Corp. Triazole derivatives as hsp90 inhibitors
JP6469567B2 (ja) * 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Egfr発動性がんの細胞増殖阻害用化合物
US20130310340A1 (en) * 2012-05-16 2013-11-21 Rigel Pharmaceuticals, Inc. Method of treating muscular degradation
WO2013177092A1 (en) 2012-05-23 2013-11-28 Sunshine Lake Pharma Co., Ltd. Substituted alkynyl pyridine compounds and methods of use
WO2013192512A1 (en) 2012-06-22 2013-12-27 Concert Pharmaceuticals, Inc. Derivatives of pyrazole-substituted amino-heteroaryl compounds
WO2014002922A1 (ja) 2012-06-26 2014-01-03 アステラス製薬株式会社 抗癌剤の併用による癌治療方法
EP2867233A1 (en) 2012-07-03 2015-05-06 Aurigene Discovery Technologies Limited 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
KR101446742B1 (ko) 2012-08-10 2014-10-01 한국화학연구원 N2,n4-비스(4-(피페라진-1-일)페닐)피리미딘-2,4-디아민 유도체 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
AU2013307383A1 (en) 2012-08-27 2015-03-26 Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh Aminoheteroaryl compounds as MTH1 inhibitors
US10053477B2 (en) 2014-07-04 2018-08-21 Qilu Pharmaceutical Co., Ltd. Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide

Similar Documents

Publication Publication Date Title
JP2017521436A5 (OSRAM)
CY1118435T1 (el) Παραγωγο μορφολινο νουκλεϊνικου οξεος
CY1119422T1 (el) Παραγωγα μπετουλινης
CY1122138T1 (el) Νεα ενωση και διαδικασια
EA201890751A1 (ru) Противогрибковые соединения и способы их получения
PH12013501197B1 (en) Indeno-fused ring compounds
JP2016506958A5 (OSRAM)
JP2018531941A5 (OSRAM)
JP2016520672A5 (OSRAM)
EA201890899A1 (ru) Модуляторы фарнезоидного x-рецептора
CY1123514T1 (el) Κρυσταλλικο 2-φθορο-3-νιτροτολουολιο και διαδικασια για την παρασκευη του
JP2015532645A5 (OSRAM)
JP2015527363A5 (OSRAM)
CY1125198T1 (el) Ενωσεις και αναλογα 1-ετεροκυκλικου ισοχρωμανυλιου για την αντιμετωπιση διαταραχων του κνς
MX390748B (es) Composiciones y metodos para tratar accidente cerebrovascular isquemico.
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
WO2018029711A3 (en) Process for the preparation of venetoclax
CY1124643T1 (el) Νεα ενωση και φαρμακευτικα αποδεκτο αλας αυτης
MX373659B (es) Metodo para producir un pentapeptido sintetico.
WO2014108795A9 (en) An improved process for the preparation of chiral diol sulfones and statins
CY1125355T1 (el) Πεντακυκλικη ενωση
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
RU2019131147A (ru) Новые хиназолиноновые производные, ингибирующие pi3k, и содержащая их фармацевтическая композиция
JO3742B1 (ar) مركب بيرانو داي بيريدين
WO2015155453A3 (fr) Nouveaux composes organo-selenies, procédé de fabrication et applications en pharmacie notamment comme agents anti-tumoraux